NCT07197775View on ClinicalTrials.gov

Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

May 31, 2032

Study Completion Date

May 31, 2032

Conditions

Type 2 Diabetes Mellitus (T2DM)Type2DiabetesDiabetes Mellitus, Type 2Type 2 DiabetesDiabetes

Sponsors

Lead Sponsor

Endogenex, Inc.

All Listed Sponsors

lead

Endogenex, Inc.

INDUSTRY